Furthermore, as the effect of hyperthermia on apoptosis can be enhanced by inhibition of Ku80, down-regulation of Ku80 expression combined with hyperthermia will be a potential strategy for RCC therapy. The gene discussed is XRCC5; the disease is renal cell carcinoma.